Full Press Release Details
Olivier Danos Joins Biogen Idec as Senior Vice President, Gene Therapy.
BIIB
Olivier Danos Joins Biogen Idec as Senior Vice President, Gene Therapy
Key Takeaway: Olivier Danos Joins Biogen Idec as Senior Vice President, Gene Therapy
BiopharmaWatch Analysis
From our catalyst data and publicly available data · not financial adviceBest trade, last catalyst
+34%
120-day peak, hindsight
Typical move
1.8%
average across 15 past catalysts
Lead asset
Alefacept
Phase 3 · Chronic Plaque Psoriasis